
The head of the FMBA Veronika Skvortsova reported on the favorable safety profile of the drug
AI-generated summary
The drug is intended for the prevention and treatment of allergic rhinoconjunctivitis.
Brief retelling from RIA II
Allergy vaccine "Allergarda" is registered in Russia for the prevention and treatment of allergic rhinoconjunctivitis.
The head of the FMBA, Veronika Skvortsova, said that the safety profile of the vaccine is assessed as favorable, and no serious adverse events have been registered.
MOSCOW, September 30 - RIA Novosti. The safety profile of the Allergarda allergen vaccine is assessed as favorable; no serious adverse events have been registered, said Veronika Skvortsova, head of the FMBA.

The governor of the Yaroslavl region, Mikhail Evraev, said that more than 30 zemstvo doctors and paramedics will come to work in the rural areas of the region this year, including 23 doctors. To attract specialists, the “Zemsky Doctor” and “Zemsky Paramedic” programs are used with payments of up to 1.5 million rubles, new first-aid posts and outpatient clinics are being built, and modern equipment is being purchased.

Leptospirosis, transmitted through contaminated water, is spreading in the flooded city of Rayong in Thailand, where hundreds of Russians may be present. Volunteers and tourists helping to clear the rubble are at risk. As of September 30, 46 deaths were recorded.

Ohio resident Sharon Jacks, 74, has filed a lawsuit against Selby General Hospital, where her left leg was mistakenly amputated during surgery in September 2025 instead of part of her right, resulting in the subsequent loss of both legs and is seeking compensation for gross negligence and criminal negligence of the medical staff.

A University of North Dakota study of 371,000 people found that regular consumption of whole fruits reduced the risk of cardiovascular disease, unlike fruit juices, which found no such association.

The Russian Ministry of Health has registered the Allergarda vaccine for the treatment of allergic rhinoconjunctivitis. The drug is also effective in treating cross food allergies caused by birch pollen.

The Ministry of Health of the Russian Federation has registered the Allergarda vaccine against allergies to birch pollen. Developed by the FMBA and the University of Vienna, the drug requires only 3-5 injections instead of the standard course of ASIT and is produced in Russia by the companies Nanolek and Generium.